Cambridge Investment Research Advisors, Inc. Wave Life Sciences Ltd. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.9 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 03, 2022	SELL	$3.14 - $5.15 $50,240 - $82,400	-16,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$5.65 - $7.47 $90,400 - $119,520	16,000 New	16,000 $106,000

Others Institutions Holding WVE

# of Institutions

192

Shares Held

122M

Call Options Held

430K

Put Options Held

330K

Ra Capital Management, L.P. Boston, MA

18.2M
Shares

$176 Million
3.65% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

9.62M
Shares

$93 Million
0.22% of portfolio
Lee Ainslie Maverick Capital LTD | Dallas, Tx

8.26M
Shares

$79.9 Million
1.98% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$65.2 Million
0.0% of portfolio
Driehaus Capital Management LLC Chicago, IL

6.71M
Shares

$64.9 Million
0.81% of portfolio

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $840M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account